Research and Development

Every year, thousands of pharma employees spend endless hours in meetings discussing, building and presenting brand plans. Countless teams develop …

Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …

Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …

The shuttering of AstraZeneca’s R&D site at Charnwood in Leicestershire has had a positive effect on the region’s life sciences …

Eli Lilly has appointed ex-investment banker Jackson Tai to its Board to serve on the Audit and Finance Committee from …

LEO Pharma has announced that it will start releasing clinical trial data from studies dating back to almost 25 years …

IT giant IBM has teamed up with the University Hospital in Zurich to research a new oncology diagnostic test, in …

Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …

Research tools firm Horizon Discovery has confirmed that David Evans has stepped down as chairman of its Board. Dr Ian …

Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team. 

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …

Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …

Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …

Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …